PROJECT

Projects

Environmental & Social Review Summary

Project Number

37926

Company Name

MED LIFE S.A.

Date ESRS Disclosed

Mar 18, 2016

Country

Romania

Region

Europe

Last Updated Date

Jun 12, 2021

Environmental Category

B - Limited

Status

Completed

Previous Events

Approved : Aug 23, 2016
Signed : Sep 30, 2016
Invested : Nov 18, 2016

Sector

Hospitals and Clinics

Industry

Health, Education and Life Sciences

Department

Regional Industry MAS LAC & EUR

Project Description

The proposed investment consists of an A-loan of up to €13.6 million to MedLife (the “company”) to support its €55million 2015-17 expansion plan (the “project”) in Romania which includes; (i) expanding operations within Romania, including new acquisitions in Bucharest, Craiova, Timisoara and Oradea; and (ii) broadening its health services offering both by acquisition and by new asset construction.

MedLife is a health care provider chain in Romania with 13 multidisciplinary clinics, 10 monodisciplinary clinics, 8 medical laboratories, 6 multi and monodisciplinary hospitals, 3 maternity hospitals and 11 pharmacies located in several cities in Romania, but mainly in Romania’s capital, Bucharest. There is no emergency services at the hospitals and no ambulance services is provided by the company. MedLife provides health services to two million in and out patients annually and has over 600 beds in its existing hospitals. The company is now expanding in Romania, especially in Bucharest, Craiova, Timisoara and Oradea, by acquisition of existing health care facilities, including hospitals, laboratories and clinics. With implementation of the expansion plan, the company targets to reach some 2.5 million patients and have over 750 beds.

The company offers a wide range of treatment services including orthopedics and traumatology, plastic and reconstructive surgery, general surgery, gynecology, pediatric surgery, genitourinary surgery, spinal surgery, ear-nose-throat surgery, oncology and surgical oncology, infertility and assisted reproduction, medical genetics and medical checkups. Laboratory services include predisposition tests for common diseases, colorectal cancer, hereditary breasts and ovarian cancer, ontogenetic tests, pharmacogenetics tests, diagnosis of thrombophilia, identification of the mutations, prenatal diagnosis, infertility tests, paternity tests and diagnosis for infectious agents. Radiology services are offered, however there is no chemotherapy unit in existing facilities.

Overview of IFC's Scope of Review

The scope of review for this project included assessment of the company’s environmental, health and safety and social (EHSS) management capacity and performance in relation to IFC’s Performance Standards, national regulatory requirements and the relevant World Bank Group’s (WBG) Environmental Health and Safety (EHS) Guidelines. The review relied on documents and reports made available by Medlife and observation and interviews by IFC staff during a site visit conducted on February 8th, 2016. Interviews included MedLife’s key staff; CFO; construction project manager (responsible for renovation and contractor management); company’s legal counsel; administration director; administration manager (human resources manager); hospitals director and a laboratory manager.

During the visit, the company’s two existing hospitals (Life Memorial Hospital and Titan Hospital in Bucharest), one laboratory (Grivitei, Bucharest) and the head office in Bucharest were visited.

IFC currently has two loans (project # 25069 and # 29638, disclosed on august 7, 2006 and May 24, 2010 respectively) and holds 12.75% equity stake in MedLife. The company has made good progress in complying with IFC environmental and social (E&S) requirements and the associated performance of the existing projects has been satisfactory based on IFC supervision to date.

E & S Project Categorization and Applicable Standard

Environmental and Social Mitigation Measures

Stakeholder Engagement

Broad Community Support

Environmental & Social Action Plan